DEFEROXAMINE MESYLATE FOR INJECTION
DEFEROXAMINE MESYLATE FOR INJECTION
Approved
DIN Number
02247022
Drug Class
Human
Market Date
Jan 12, 2004
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02247022
AIG Number0109208001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AC01 DEFEROXAMINE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationSubcutaneous
,
Intraperitoneal
,
Intravenous
,
Intramuscular
AHFS Classification64:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DEFEROXAMINE MESYLATEActive
Strength: 2 G / VIAL
Monograph: DEFEROXAMINE MESYLATE